With snowballing healthcare spending and the emergence of new modalities of treatments, discussions are heating up around revisiting the scope of health coverage on pharmaceuticals, with the Ministry of Finance (MOF) and payers advocating the mantra of “large risks with…
HOME > ACADEMIA
ACADEMIA
- Discussions on New Guidelines for Atherosclerosis Prevention Get Underway
February 9, 2016
- Japan Oncology Society Calls for Proper Use of Opdivo
January 22, 2016
- Experts Launch Japanese Society of Geriatric Pharmacy
January 7, 2016
- Shionogi Funding Research to Develop World’s First Drug for Preventing Postoperative Metastasis of Lung Cancer
January 5, 2016
- Over 200 Medical Institutions, 14 Drug Makers Participating in Project to Analyze Cancer-Related Genetic Disorders
December 14, 2015
- Viekirax Joins Fray in Hep C Market, Can It Crack into Harvoni’s Stronghold?
November 20, 2015
- Japan Geriatrics Society to Publish Guidelines for Safe Pharmacotherapy in the Elderly Next Month
November 18, 2015
- Japan Sepsis Management Guidelines to Be Revised Next Year
October 27, 2015
- Group Calls for Appropriate Dosing of Dementia Drugs
October 9, 2015
- Asia, Oceania Obesity Associations Adopt Declaration on “Obesity Disease”
October 6, 2015
- New Guidelines for Obesity Treatment to Set Thresholds to Evaluate Drugs
October 6, 2015
- Japan Hypertension Society Announces COI Guide after Diovan Woes
October 5, 2015
- JSNP Finalizes Evidence-Based Guidelines for Treatment of Schizophrenia
September 28, 2015
- Experts, Industry Execs Say Cost Calculation Drug Pricing Method Fraught with Challenges
September 8, 2015
- ASCO Immunotherapy Roundup - 9: Researcher Says Predominance of Anti-PD-1 Antibodies Not Assured
September 1, 2015
- Japan’s National Database “World’s Largest in Scale”: Kyoto University Prof. Nakayama
August 20, 2015
- Genome Sequencing Study of Biliary Tract Cancer Suggests Effectiveness of Immune Checkpoint Therapy: National Cancer Center
August 12, 2015
- St. Marianna Univ. Hospital Introduces Tougher Rules for Adopting New Drugs with Emphasis on Cost, Efficacy, and Safety
July 28, 2015
- PD-L1 Expression Key to Decide Whether to Combine Opdivo, Yervoy: Oncologist
July 21, 2015
- Japan, US Oncologists Exchange Barbs over Opdivo Costs
July 21, 2015
ページ
As Japan gears up for its next drug pricing reform in April 2020, Shoji Kono, director of the National Federation…
Pharmaceutical sales per rep in Japan, a yardstick for “productivity” at drug makers, reached a record 172 million yen in FY2018, up 20 million yen from five years ago, as companies continue ramping up their job-shedding drive in a bid…
Riding on the back of an improved regulatory environment in China, major Japanese drug makers are moving to expand their businesses in the world’s second largest pharma market. Companies are pumping up their new drug pipelines, while forging solid sales…
Japan’s generic market is hitting a plateau soon. Incentive measures rolled out by the government since 2002 have driven its…
Some seven years in the making, Japan’s Ministry of Health, Labor and Welfare (MHLW) finally rolled out a cost-effectiveness assessment…
Japan will go ahead with the introduction of a cost-effectiveness assessment (CEA) scheme for drugs and medical devices in April…
In my home country of Australia, there is a famous candy called “Minties”. Minties has a long-running advertising campaign, presenting comical situations, with the caption, “It’s moments like these.” The phase has become part of the Aussie vernacular, meaning in…